MX2013002268A - Metodos para detectar anticuerpos anti-he4 y metodos de diagnosis y/o de prognosis de condiciones asociadas con celulas que expresan he4. - Google Patents
Metodos para detectar anticuerpos anti-he4 y metodos de diagnosis y/o de prognosis de condiciones asociadas con celulas que expresan he4.Info
- Publication number
- MX2013002268A MX2013002268A MX2013002268A MX2013002268A MX2013002268A MX 2013002268 A MX2013002268 A MX 2013002268A MX 2013002268 A MX2013002268 A MX 2013002268A MX 2013002268 A MX2013002268 A MX 2013002268A MX 2013002268 A MX2013002268 A MX 2013002268A
- Authority
- MX
- Mexico
- Prior art keywords
- antibodies
- biological sample
- amount
- cancer
- sequence
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37738710P | 2010-08-26 | 2010-08-26 | |
| PCT/US2011/049274 WO2012027631A2 (en) | 2010-08-26 | 2011-08-26 | Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2013002268A true MX2013002268A (es) | 2014-02-03 |
Family
ID=45724080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013002268A MX2013002268A (es) | 2010-08-26 | 2011-08-26 | Metodos para detectar anticuerpos anti-he4 y metodos de diagnosis y/o de prognosis de condiciones asociadas con celulas que expresan he4. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20130224772A1 (https=) |
| EP (1) | EP2609429B1 (https=) |
| JP (1) | JP6097688B2 (https=) |
| CN (1) | CN103180732B (https=) |
| AU (1) | AU2011293217A1 (https=) |
| BR (1) | BR112013004458A2 (https=) |
| CA (1) | CA2809368C (https=) |
| MX (1) | MX2013002268A (https=) |
| RU (1) | RU2600891C2 (https=) |
| WO (1) | WO2012027631A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7270960B2 (en) * | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
| RU2650778C2 (ru) * | 2011-02-17 | 2018-04-17 | Фуджиребио Диагностикс, Инк | Композиции и способы применения для определения не4а |
| CN103424551B (zh) * | 2013-08-06 | 2015-08-26 | 江苏福隆生物技术有限公司 | 人附睾上皮分泌蛋白4定量测定试剂盒及其检测方法 |
| US10267802B2 (en) * | 2015-09-23 | 2019-04-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of prognosis and diagnosis of ovarian cancer |
| ES2792055T3 (es) * | 2015-12-17 | 2020-11-06 | Hoffmann La Roche | Métodos de detección de una recidiva de un adenocarcinoma de pulmón basándose en la proteína 4 del epidídimo humano (HE 4) marcadora y usos relacionados |
| CN109280084B (zh) * | 2018-03-09 | 2022-04-29 | 河南大学 | 一种胶体硒标记的抗he4抗体、试剂盒及其制备方法 |
| CN109480771B (zh) * | 2018-10-17 | 2021-09-07 | 江西惠肽生物科技有限公司 | 一种卵巢肿块良恶的确定方法及确定装置 |
| CN110895279B (zh) * | 2019-11-27 | 2023-02-28 | 普健生物（武汉）科技有限公司 | 一种检测人附睾分泌蛋白4的化学发光试剂盒 |
| TW202300916A (zh) * | 2021-03-22 | 2023-01-01 | 美商治療股份有限公司 | 使用唾液或鼻腔檢體之免疫評估 |
| CN113045663B (zh) * | 2021-04-18 | 2022-04-01 | 深圳市国创纳米抗体技术有限公司 | 一种抗he4的纳米抗体1a8及其应用 |
| CN117487018B (zh) * | 2023-09-27 | 2024-05-17 | 武汉爱博泰克生物科技有限公司 | 抗人附睾分泌蛋白4的兔单克隆抗体及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5017342A (en) * | 1988-06-01 | 1991-05-21 | Ortho Diagnostic Systems Inc. | Device for immunoassay determinations |
| WO2002046765A2 (en) * | 2000-11-08 | 2002-06-13 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer |
| US7270960B2 (en) * | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| CA2622332A1 (en) * | 2005-09-15 | 2007-03-22 | Val-Chum, S.E.C. | Methods of diagnosing ovarian cancer and kits therefor |
| JP5164855B2 (ja) * | 2006-01-04 | 2013-03-21 | フジレビオ アメリカ、インク． | 子宮内膜または子宮癌を評価するためのｈｅ４及びそのほかの生化学的マーカーの使用 |
| JP5495159B2 (ja) * | 2006-09-13 | 2014-05-21 | オンクイミューン リミテッド | 改善されたイムノアッセイ法 |
| BRPI0808655A2 (en) * | 2007-03-09 | 2018-10-23 | Tripath Imaging, Inc. | he4 monoclonal antibodies and methods for their use. |
| US8455189B2 (en) * | 2007-03-29 | 2013-06-04 | Jeffrey W. Allard | Use of HE4 for assessment of breast cancers |
| WO2010061393A1 (en) * | 2008-11-30 | 2010-06-03 | Compugen Ltd. | He4 variant nucleotide and amino acid sequences, and methods of use thereof |
| CN101525614A (zh) * | 2009-04-13 | 2009-09-09 | 大连美亿德生物科技有限公司 | 人卵巢癌肿瘤标志物he4酶联免疫诊断试剂盒 |
-
2011
- 2011-08-26 JP JP2013526167A patent/JP6097688B2/ja active Active
- 2011-08-26 AU AU2011293217A patent/AU2011293217A1/en not_active Abandoned
- 2011-08-26 BR BR112013004458A patent/BR112013004458A2/pt not_active IP Right Cessation
- 2011-08-26 CA CA2809368A patent/CA2809368C/en active Active
- 2011-08-26 RU RU2013113314/15A patent/RU2600891C2/ru active
- 2011-08-26 MX MX2013002268A patent/MX2013002268A/es unknown
- 2011-08-26 WO PCT/US2011/049274 patent/WO2012027631A2/en not_active Ceased
- 2011-08-26 CN CN201180051336.5A patent/CN103180732B/zh active Active
- 2011-08-26 US US13/818,466 patent/US20130224772A1/en not_active Abandoned
- 2011-08-26 EP EP11820697.8A patent/EP2609429B1/en active Active
-
2018
- 2018-01-25 US US15/879,963 patent/US20180217158A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012027631A3 (en) | 2012-07-19 |
| JP2013536442A (ja) | 2013-09-19 |
| EP2609429A4 (en) | 2014-03-19 |
| AU2011293217A1 (en) | 2013-04-11 |
| CN103180732B (zh) | 2017-09-08 |
| CA2809368C (en) | 2021-08-24 |
| JP6097688B2 (ja) | 2017-03-15 |
| CN103180732A (zh) | 2013-06-26 |
| EP2609429A2 (en) | 2013-07-03 |
| EP2609429B1 (en) | 2017-09-20 |
| CA2809368A1 (en) | 2012-03-01 |
| RU2013113314A (ru) | 2014-10-10 |
| RU2600891C2 (ru) | 2016-10-27 |
| US20180217158A1 (en) | 2018-08-02 |
| BR112013004458A2 (pt) | 2016-06-07 |
| US20130224772A1 (en) | 2013-08-29 |
| WO2012027631A2 (en) | 2012-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2809368C (en) | Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells | |
| JP5711196B2 (ja) | 卵巣癌を判定するためのｈｅ４及び他の生化学マーカーの使用 | |
| US20030232399A1 (en) | Cancer detection methods and reagents | |
| KR20080114689A (ko) | 증가된 ｂｃｌ-2에 의한 암의 발견 | |
| CN107110848B (zh) | 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法 | |
| JP2013047679A (ja) | 乳がんの評価のためのｈｅ４の使用 | |
| US20090042224A1 (en) | Methods for diagnosis and/or prognosis of ovarian cancer | |
| JP2008035836A (ja) | 腫瘍マーカー | |
| JP2021117117A (ja) | 前立腺癌のバイオマーカー及び該バイオマーカーを用いた前立腺癌を検出するための方法並びに診断キット | |
| HK1187100A (en) | Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells | |
| HK1187100B (en) | Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells | |
| HK1225411B (en) | Use of he4 and other biochemical markers for assessment of ovarian cancers | |
| HK1225411A (en) | Use of he4 and other biochemical markers for assessment of ovarian cancers | |
| HK1225411A1 (en) | Use of he4 and other biochemical markers for assessment of ovarian cancers | |
| HK1166109A (en) | Use of he4 and other biochemical markers for assessment of ovarian cancers | |
| HK1219514B (en) | Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers |